Cerus Corporation to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Cerus (Nasdaq: CERS) has announced its participation in two upcoming investor conferences. Management will present at the Stifel 2024 Healthcare Conference on Monday, November 18th at 4:10 PM ET, and attend the Craig-Hallum Alpha Select Conference on Tuesday, November 19th. A live webcast of the Stifel conference presentation will be available online, with a replay accessible on the company's website following the event.

CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) announced management participation in two upcoming investor conferences.

Management plans to participate in the Stifel 2024 Healthcare Conference on Monday, November 18^th at 4:10 PM ET, and will attend the Craig-Hallum Alpha Select Conference on Tuesday, November 19^th.

A live webcast of the Stifel 2024 Healthcare Conference will be available here and the replay will be available on the Company’s website after the event.

ABOUT CERUS

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. In the U.S., the INTERCEPT Blood System for Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex), a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. The INTERCEPT red blood cell system is in late-stage clinical development. For more information about Cerus, visit www.cerus.com and follow us on LinkedIn.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241113229565/en/

Jessica Hanover

Cerus Corporation

925-288-6137

Source: Cerus Corporation

FAQ

When is Cerus (CERS) presenting at the Stifel 2024 Healthcare Conference?

Cerus (CERS) will present at the Stifel 2024 Healthcare Conference on Monday, November 18th at 4:10 PM ET.

Which investor conferences is Cerus (CERS) attending in November?

Cerus is attending two conferences: the Stifel 2024 Healthcare Conference on November 18th and the Craig-Hallum Alpha Select Conference on November 19th.

Will there be a webcast of Cerus 's (CERS) Stifel conference presentation?

Yes, a live webcast of Cerus 's presentation at the Stifel 2024 Healthcare Conference will be available, with a replay accessible on the company's website after the event.